Sorry, you need to enable JavaScript to visit this website.

Sign Up For Mailing List Button

Disease Search Button

NETS - NDA or BLA

Facebook icon
Twitter icon
LinkedIn icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What is an NDA or BLA and why is it important in drug development?

An NDA, or "New Drug Application," is the formal method for a drug manufacturer to apply for FDA approval to begin sale and marketing of a new pharmaceutical in the US. An NDA contains every piece of information about a drug, from its chemical composition to its packaging to the results from its clinical trials. A BLA, or "Biological License Application," is very similar to an NDA, and is an application with information about the manufacturing processes, chemistry, pharmacology, clinical pharmacology and medical effects of a biologic product (a medical product isolated from a natural source such as a human, animal or microorganism). Manufacturers need approval of NDAs and BLAs before they are allowed to market their products.

Drugs must undergo a separate marketing approval process in other countries. In Europe, for example, the European Medicines Agency requires a Marketing Authorization Application (MAA). This serves a similar purpose to an NDA.

Testimonials: How we did it

Content not yet available for this section.

Related Tools

Content not yet available for this section.

 

Follow Us

Twitter icon
Facebook icon
LinkedIn icon
YouTube icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.